Fate Therapeutics Granted Exclusive License to Stem Cell Modulators for Osteo-Regeneration

News   Jul 02, 2009

 
Fate Therapeutics Granted Exclusive License to Stem Cell Modulators for Osteo-Regeneration
 
 
 

RELATED ARTICLES

New Cell Therapy for Diabetes Being Tested

News

The University of British Columbia and Vancouver Coastal Health are testing a possible diabetes cure that replaces a person’s damaged pancreatic cells with new ones grown in the lab.

READ MORE

Scleroderma Study Offers New Hope For Sufferers

News

An unusual autoimmune disease that causes skin and lung damage can be treated effectively by stem cell transplant, a new study found. The approach could represent the first new treatment to improve survival in patients with severe scleroderma in more than four decades.

READ MORE

Metrohm USA Opens Its New Headquarters in Florida

News

Metrohm USA welcomes its Tampa employees to their new North American headquarters in Riverview, Florida.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE